
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
ABT | NYSE | USD | Real-time | |
0Q15 | London | USD | Real-time | |
ABT | Mexico | MXN | Delayed | |
ABT | Switzerland | CHF | Delayed | |
ABT | Xetra | EUR | Delayed | |
ABT | Frankfurt | EUR | Delayed | |
ABT | TradeGate | EUR | Delayed | |
ABTCL | Santiago | CLP | Delayed | |
ABT | Buenos Aires | ARS | Delayed | |
ABTT34 | BM&FBovespa | BRL | Delayed | |
ABT_KZ | KASE | USD | Delayed |
Abbott Laboratories reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was USD 9,747 million compared to USD 11,895 million a year ago. Net income was USD 1,318 million compared to USD 2,447 million a year ago. Diluted earnings per share from continuing operations was USD 0.75 compared to USD 1.37 a year ago.
Period Ending: | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 |
---|---|---|---|---|
Total Revenue | 9747 | 10091 | 10410 | 11257 |
Gross Profit | 5422 | 5561 | 5781 | 6324 |
Operating Income | 1646 | 1459 | 1872 | 2482 |
Net Income | 1318 | 1033 | 1435 | 2018 |
Period Ending: | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 |
---|---|---|---|---|
Total Assets | 73794 | 74438 | 72801 | 74202 |
Total Liabilities | 36562 | 37533 | 36917 | 37486 |
Total Equity | 37232 | 36905 | 35884 | 36716 |
Period Ending: | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 1143 | 2326 | 2780 | 2410 |
Cash From Investing Activities | -462 | -632 | -484 | -264 |
Cash From Financing Activities | -1410 | -1457 | -1543 | -813 |
Net Change in Cash | -721 | 288 | 657 | 1262 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review